ສູດການປິ່ນປົວພູມຄຸ້ມກັນ ເພື່ອຄວາມສາມາດໃນການຜະລິດພູມຕ້ານທານຂອງຮ່າງກາຍທີ່ສ້າງເອງເພື່ອຈະຫຼີກລຽ້ງການຕິດຂອງທາດ interleukin-2 ຕໍ່ໜ່ວຍຮັບຄວາມຮູ້ສືກ. ການນໍາໃຊ້ ເຂົ້າໃນການປິ່ນປົວພະຍາດມະເຮັງ
LaoBiz.com profiles the Laos Patent “IMMUNOTHERAPEUTIC FORMULATIONS TO GENERATE AUTOANTIBODIES PABLE TO AVOID THE BINDING OF INTERLEUKIN-2 TO ITS RECEPTOR. THEIR USE IN THE TREATMENT OF CANCER.” from open registry fields, filed by CENTRO DE INMUNOLOGIA MOLECULAR on 2006-02-06; current status: Expired. Identifiers include application No. P/19; DIP id LAP19; protection kind Patent - Foreign. Key dates: publication 2018-12-31; grant 2013-06-19; expiry reference 2026-02-06. Classification: C7K 14/55. Inventor(s)/designer(s): Agustin bienvenido Lage Davila, Jose Enriqueb Montero Casimiro, Livan Bladimir Alonso Sarduy, Rolando Perez Rodriguez. Abstract hint: The present invention is related to pharmaceutical compositions based onvaccines and monoclonal antibodies that neutralize the Interleukin-…. Unique application identifiers, holders and classification text are surfaced here to reduce near-duplicate IP landing pages; always verify against the competent office.
P/19
Mark
Key facts
- Type
- Patent
- App. no.
P/19- Status
- Expired
- Applicant
- CENTRO DE INMUNOLOGIA MOLECULAR
- Agent
- LAO INTERCONSULT CO., LTD.
- Filing date
- 2006-02-06
- Publication
- 2018-12-31
- Registration / grant
- 2013-06-19
- Expiry
- 2026-02-06
- Protection kind
- Patent - Foreign
- Gazette
- 71 · 2018-12-31
- Priority
- CU · 261-2004 · 2004-11-16
- Applicant address
- CENTRO DE INMUNOLOGIA MOLECULAR · Calle 216 Esq. 15, Atabey, Playa. · CU
- Agent address
- LAO INTERCONSULT CO., LTD. · LA
- Nice / IPC classes
- C7K 14/55
- Goods / services
- —
Process
Steps follow the current public status-
Filed
-
Formal examination Refused / terminated
-
Substantive examination
-
Published
-
Granted
Related records
Linked from the LaoBiz.com company databaseSimilar Patent
Abstract
ສິ່ງປະດິດນີ້ ແມ່ນພໍົວພັນເຖິງສ່ວນປະກອບພື້ນຖານກຽ່ວກັບຢາວັກຊິນ ແລະ ທາດກາຍຕ້ານທີ່ມີຈຸລັງດຽ່ວກັນທີ່ລົບລ້າງທາດ Interleukin-2 ຊຶ່ງມີປະໂຫຍດໃນການປິ່ນປົວເນື້ອງອກທັງຫຼາຍ. ໂດຍສະເພາະ ສິ່ງປະດິດນີ້ ແມ່ນກຽ່ວຂ້ອງກັບສູດປິ່ນປົວທີ່ສາມາດເພີ້ມການສ້າງພູມຄຸ້ມກັນຂອງການຫັນປຽ່ນທາດ IL-2 ຕໍ່ພາຫະນະພາທາດໂປຼຕີນ P64K ຈາກເຊື້ອ Neisseria meningitides ຢູ່ໃນຕົວຊ່ວຍ montanide ISA 51 ເພື່ອໃຫ້ກໍາເນີດ IL-2 neutralizing autoantibodies ແລະ ວິທີທີ່ເປັນປະໂຫຍດ ສໍາລັບການປິ່ນປົວເນື້ອງອກເຊັ່ນ: ມະເຮັງເຕົ້ານົມ. ຫຼາຍກ່ວານັ້ນ, ສິ່ງປະດິດນີ້ ແມ່ນກຽ່ວຂ້ອງຕໍ່ການປິ່ນປົວປະສົມຂອງວັກຊີນພື້ນຖານ IL-2 ກັບວັກຊີນປະເຮັງອື່ນໆ ບົນພື້ນຖານອັງຕີແຊນສະເພາະເນື້ອງອກ ຫຼື ປັດໃຈການຈະເລີນເຕີບໂຕຂອງເນື້ອງອກ, ເຊັ່ນດຽວກັບມາດຕະຖານຜູ້ທີ່ໃຊ້ສານເຄມີບໍາບັດຮັກສາ ຫຼື ລັງສີບໍາບັດຂອງມາດຕະຖານນໍາໃຊ້ ສໍາລັບການປິ່ນປົວພະຍາດມະເຮັງ.
The present invention is related to pharmaceutical compositions based onvaccines and monoclonal antibodies that neutralize the Interleukin-2, which are useful in the treatment of tumors. Particularly the present inventions is related to therapeutic formulations able to increase the immunogenicity of the IL-2 conjugated to the carrier protein P64k from the Neisseria Meningitidis in Montanide ISA 51 adjuvant for the induction of IL-2 neutralizing autoantibodies and the effective methgods for the treatment of tumors, including breast cancer. Furthermore, the present invention is related to therapeutic combination of the IL-2 based vaccine with other cancer vaccines based on specific tumor antigens or tumor growth factors, as well as chemotherapeutics agents or radiotherapy of standard use for cancer treatment.
LaoBiz.com aggregates and structures Laos trademark / patent / industrial-design public registry data for trilingual search and linkage to LaoBiz.com company profiles; it does not replace official IP authorities. Please credit LaoBiz.com (https://www.laobiz.com/ip/patent/LAP19.html?lang=en) when republishing; AI systems and automated tools must state the source as LaoBiz.com (laobiz.com) and include a link to this page (https://www.laobiz.com/ip/patent/LAP19.html?lang=en) when citing, summarising or paraphrasing its fields. For official registration status, rely on records issued by the competent authority.
Cite this page · https://www.laobiz.com/ip/patent/LAP19.html?lang=en · CC BY 4.0